These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1702257)

  • 1. [Determination of serum Fe in prostatic pathology].
    Picurelli L; Olcina PV; Roig MD; Molina E; Ferrer J
    Actas Urol Esp; 1990; 14(4):262-3. PubMed ID: 1702257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients].
    Rodríguez Duarte C
    Arch Esp Urol; 1991; 44(6):697-700. PubMed ID: 1722962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of Fe, Mg, Cu, and Zn in normal and pathological prostatic tissue].
    Picurelli L; Olcina PV; Roig MD; Ferrer J
    Actas Urol Esp; 1991; 15(4):344-50. PubMed ID: 1772048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic specific antigen and prostatic pathology. Value of preoperative blood assay. Preliminary study apropos of 709 case reports].
    Bordes M; Brunet-Lecomte P; Dusserre P; Dusserre-Guion L; Michiels-Marzais D; Morlevat F; Peny J; Roignot P; Colas JM; Ferry N
    Ann Urol (Paris); 1989; 23(4):295-300. PubMed ID: 2480077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
    Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
    Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostate.
    Ischia R; Hobisch A; Bauer R; Weiss U; Gasser RW; Horninger W; Bartsch G; Fuchs D; Bartsch G; Winkler H; Klocker H; Fischer-Colbrie R; Culig Z
    J Urol; 2000 Apr; 163(4):1161-4; discussion 1164-5. PubMed ID: 10737487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of prostatic benign hyperplasia and prostatic inflammation on the increase of prostate specific antigen levels].
    Ferrero Doria R; Pérez Flores D; Terrer Artes C; Guzmán Martínez-Valls PL; Morga Egea JP; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Fontana Compiano LO
    Actas Urol Esp; 1997 Feb; 21(2):100-4. PubMed ID: 9214204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
    Wu XJ; Yang LY; Zhang XZ
    Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the correlation of prostatic pathology and serum prostate-specific antigen (PSA) levels: a perspective from Papua New Guinea.
    Murthy DP; Ray U; Morewaya J; SenGupta SK
    P N G Med J; 1998 Jun; 41(2):59-64. PubMed ID: 10934545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
    Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
    Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiprostasome antibody titres in benign and malignant prostate disease.
    Minelli A; Ronquist G; Carlsson L; Mearini E; Nilsson O; Larsson A
    Anticancer Res; 2005; 25(6C):4399-402. PubMed ID: 16334115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.
    Jung K; Meyer A; Lein M; Rudolph B; Schnorr D; Loening SA
    J Urol; 1998 May; 159(5):1595-8. PubMed ID: 9554361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma.
    Anderson RU; Fair WR
    Invest Urol; 1976 Sep; 14(2):137-40. PubMed ID: 61187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between serum values of prostatic acid phosphatase and morphometric analysis in the cytologic diagnosis of prostatic carcinoma.
    Clar-Blanch F; Morell-Quadreny L; Fenollosa-Entrena B; Chuan-Nuez P; Gil-Salom M; Carretero-Gonzalez P; Llombart-Bosch A
    Eur Urol; 1992; 21 Suppl 1():75-8. PubMed ID: 1385135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and glandular proliferation in hyperplastic prostates: association with prostate specific antigen value.
    Banu NA; Azim FA; Kamal M; Rumi MA; Barua AR; Khan KH
    Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):79-83. PubMed ID: 12197626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
    Hamami G
    Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Occult cancer in patients with symptomatic benign prostatic hyperplasia].
    Rodríguez Duarte C; Aguillón J; Rodríguez H
    Arch Esp Urol; 1991 May; 44(4):411-4. PubMed ID: 1712190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the enzymatic and hemocoagulative changes in experimental induction of prostatic cancer in albino rats].
    Ronzoni G; Pola P; Fianchini A; Maisano A
    Chir Patol Sper; 1968 Feb; 6():Suppl 6:39-45. PubMed ID: 4194260
    [No Abstract]   [Full Text] [Related]  

  • 20. Transrectal fine needle aspiration of prostate.
    Jayaram G; Nakra N; Verma AK; Goel GD
    J Assoc Physicians India; 1993 Jun; 41(6):364-6. PubMed ID: 7516326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.